Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03680560
Title Study of ACTR T Cell Product in Combination With Trastuzumab in Subjects With HER2-Positive Advanced Solid Tumor Cancers
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Unum Therapeutics Inc.
Indications

Advanced Solid Tumor

Therapies

ACTR707 + Trastuzumab

ACTR087 + Trastuzumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.